Canine Glioma
Clinical Trial
Duke University Pratt School of Engineering in collaboration with the University of Minnesota College of Veterinary Medicine is now recruiting canine glioma patients to be enrolled in a new clinical trial
Overview
The goal of this trial is to offer cutting edge therapy to eligible dogs with brain tumors intended to preserve the quality of life and improve long-term survival rates. Additionally, we will use the information gained from treating dogs to design similar treatments for people with brain tumors.
Our experienced collaborators at the University of Minnesota, College of Veterinary Medicine, have treated over 200 dogs with brain tumors under other trials. The goal of this new trial is to provide treatment to dogs with canine using a specialized catheter system that draws tumor cells out of the brain.
The majority of the costs associated with these experimental brain tumor therapies are paid for by grants from foundations and government agencies.
Breakthrough Designation
While still at the preclinical stage, this novel approach to treat brain tumors has already been published and peer-reviewed in high impact scientific journals (including prestigious Nature Materials), and recently received a Breakthrough Designation from the FDA to ultimately be studied in human patients with high priority.
How To participate
We have people coming from near and far to participate in these studies. For all interested, see the steps below.
1. Your veterinarian can use the link to the right to request enrollment of a dog in a trial: "Apply for Brain Tumor Clinical Trials Program", or you may contact Dr. Pluhar directly (see below).
2. In order to determine if the tumor is operable and your dog is eligible for the study, Dr. Pluhar must be able to review the MRI.
3. Once Dr. Pluhar reviews the images, she will be in touch with the owner or veterinarian with the next steps.
Dogs with glioma, as seen on MRI contact Dr. Pluhar at 612-625-1162, pluha006@umn.edu
© 2019